Published in Cancer Weekly, October 6th, 2009
"We're thrilled to see this project come together like it has," said Russell Budd, Baron & Budd managing shareholder. "We wanted to inform people about the serious nature of this disease and to provide resources for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.